7 results
8-K
EX-10.7
AVRW
Avenir Wellness Solutions, Inc.
28 Jul 22
CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million
9:51am
or indirectly, recruit or otherwise solicit or induce any customer, subscriber or supplier of the Company to (A) terminate or reduce its arrangement
8-K
EX-10.2
AVRW
Avenir Wellness Solutions, Inc.
5 Oct 20
Entry into a Material Definitive Agreement
8:16am
(as defined below), directly or indirectly, recruit or otherwise solicit or induce any customer, subscriber or supplier of the Company to (A) terminate
8-K
EX-10.1
wy8u 4wdptqh8zjb5
20 May 19
CURE Pharmaceutical Expands Leadership Team with Key New Hires
4:39pm
- Prev
- 1
- Next